Navidea Biopharmaceuticals, Inc.
11
J Kate Stickles
10/01/2025
01/18/2026
Yes
v
| CLMSAGNT, PlnDue, Subchapter_V, SealedDoc(s), SEALEDMATRIX |
Assigned to: Bankruptcy Judge J Kate Stickles Chapter 11 Voluntary Asset |
|
Debtor Navidea Biopharmaceuticals, Inc.
4100 Horizons Drive Suite 205 Columbus, OH 43220 FRANKLIN-OH Tax ID / EIN: 31-1080091 |
represented by |
Joseph C. Barsalona II
Pashman Stein Walder Hayden, P.C. 824 North Market Street, Suite 800 Wilmington, DE 19801 302-592-6497 Email: jbarsalona@pashmanstein.com Michael J. Custer
Pashman Stein Walder Hayden 824 North Market Street Suite 800 Wilmington, DE 19801 302-327-6791 Email: mcuster@pashmanstein.com Alexis R. Gambale
Pashman Stein Walder Hayden, P.C. 824 North Market Street Suite 800 Wilmington, DE 19801 856-316-6597 Email: agambale@pashmanstein.com |
Trustee David M. Klauder
Bielli & Klauder LLC 1204 N. King Street Wilmington, DE 19801 302-803-4600 |
represented by |
Ryan Ernst
Bielli & Klauder, LLC 1204 North King Street Wilmington, DE 19801 302-321-5411 Fax : 302-397-2557 Email: rernst@bk-legal.com David M. Klauder
Bielli & Klauder, LLC 1204 N. King Street Wilmington, DE 19801 302-803-4600 Fax : 302-397-2557 Email: dklauder@bk-legal.com |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
represented by |
Hannah J McCollum
DOJ-Ust 844 King St., Suite 2207 Lockbox 35 Wilmington, DE 19801 202-573-3275 Email: hannah.mccollum@usdoj.gov |
Claims Agent Epiq Corporate Restructuring, LLC
777 Third Avenue 12th Floor New York, NY 10017 212-225-9200 Tax ID / EIN: 33-1041096 |
| Date Filed | # | Docket Text |
|---|---|---|
| 12/11/2025 | 166 | Order (I) Approving Bid Procedures, (II) Scheduling Bid Deadline and Auction (III) Approving the Form and Manner of Notice Thereof, (IV) Approving Procedures for the Assumption and Assignment of Contracts and Leases, and (V) Granting Related Relief ( (Related Doc # 146)(related document(s)146) Order Signed on 12/11/2025. (Attachments: # 1 Exhibit 1 # 2 Exhibit 2 # 3 Exhibit 3) (AJL) (Entered: 12/11/2025) |
| 12/11/2025 | 165 | Notice of Agenda of Matters Scheduled for Hearing Filed by Navidea Biopharmaceuticals, Inc.. Hearing scheduled for 12/15/2025 at 01:00 PM at US Bankruptcy Court, 824 Market St., 5th Fl., Courtroom #6, Wilmington, Delaware. (Gambale, Alexis) (Entered: 12/11/2025) |
| 12/11/2025 | 164 | Notice of Rescheduled Hearing /Notice of Rescheduled Omnibus Hearing Hearing Originally Scheduled for January 23, 2026 has been rescheduled. Filed by Navidea Biopharmaceuticals, Inc.. Hearing scheduled for 1/29/2026 at 02:30 PM at US Bankruptcy Court, 824 Market St., 5th Fl., Courtroom #6, Wilmington, Delaware. (Gambale, Alexis) (Entered: 12/11/2025) |
| 12/11/2025 | 162 | Certification of Counsel Regarding Debtor's Motion for Entry of an Order (I) Approving Bid Procedures, (II) Scheduling Bid Deadline and Auction (III) Approving the Form and Manner of Notice Thereof, (IV) Approving Procedures for the Assumption and Assignment of Contracts and Leases, and (V) Granting Related Relief (related document(s)146, 156) Filed by Navidea Biopharmaceuticals, Inc.. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Gambale, Alexis) (Entered: 12/11/2025) |
| 12/10/2025 | 163 | Order: (I) Authorizing the Debtor to Employ and Retain SSG Advisors, LLC as Investment Banker to the Debtor Nunc Pro Tunc to the November 24, 2025, (II) Approving the Terms of the Engagement Agreement, (III) Modifying Certain Time-Keeping Requirements; and (IV) Granting Related Relief ( (Related Doc # 147)(related document(s)158) Order Signed on 12/10/2025. (AJL) (Entered: 12/11/2025) |
| 12/10/2025 | 161 | Order Approving Application Of Subchapter V Trustee David M. Klauder, Pursuant To 11 U.S. C. Sections 327 And 328(a) And Federal Rule Of Bankruptcy Procedure 2014, For Authority To Employ And Retain Bielli & Klauder, LLC As Counsel To The Subchapter V Trustee For This Case Nunc Pro Tunc To November 13, 2025 (Related Doc # 142)(related document(s)142) Order Signed on 12/10/2025. (AJL) (Entered: 12/10/2025) |
| 12/10/2025 | 160 | Certificate of Mailing of Claims Agent re Debtor's Motion for an Order (I) Authorizing Payment of Prepetition Claims of Certain Critical Vendors and (II) Granting Related Relief; Second Application for Compensation of Pashman Stein Walder Hayden, P.C. as Counsel for the Debtor and Debtor in Possession, for Allowance of Monthly Compensation and for Monthly Reimbursement of All Actual and Necessary Expenses Incurred for the period November 1, 2025 to November 30, 2025. Filed by Epiq Corporate Restructuring, LLC. (related document(s)153, 154) (Mailloux, Kathryn) (Entered: 12/10/2025) |
| 12/09/2025 | 159 | Certificate of No Objection to the Application of Subchapter V Trustee David M. Klauder, Pursuant to 11 U.S.C. §§ 327(a) and 328(a) and Federal Rule of Bankruptcy Procedure 2014, for Authority to Employ and Retain Bielli & Klauder, LLC as Counsel to the Subchapter V Trustee for this Case Nunc Pro Tunc to November 13, 2025 (related document(s)142) Filed by David M. Klauder. (Klauder, David) (Entered: 12/09/2025) |
| 12/09/2025 | 158 | Certification of Counsel Regarding Debtor's Application for Entry of an Order: (I) Authorizing the Debtor to Employ and Retain SSG Advisors, LLC as Investment Banker to the Debtor Nunc Pro Tunc to the November 24, 2025, (II) Approving the Terms of the Engagement Agreement, (III) Modifying Certain Time-Keeping Requirements; and (IV) Granting Related Relief (related document(s)147) Filed by Navidea Biopharmaceuticals, Inc.. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Gambale, Alexis) (Entered: 12/09/2025) |
| 12/08/2025 | 157 | Exhibit(s) /Notice of Updated DIP Budget (related document(s)12, 13, 32, 122, 133) Filed by Navidea Biopharmaceuticals, Inc.. (Attachments: # 1 Exhibit A) (Gambale, Alexis) (Entered: 12/08/2025) |